Literature DB >> 29353375

Comparative Effects of Hydrogen Sulfide-Releasing Compounds on [3H]D-Aspartate Release from Bovine Isolated Retinae.

Pratik Bankhele1, Ankita Salvi1, Jamal Jamil1, Fatou Njie-Mbye2, Sunny Ohia2, Catherine A Opere3.   

Abstract

We investigated the pharmacological actions of a slow-releasing H2S donor, GYY 4137; a substrate for the biosynthesis of H2S, L-cysteine and its precursor, N-acetylcysteine on potassium (K+; 50 mM)-evoked [3H]D-aspartate release from bovine isolated retinae using the Superfusion Method. GYY 4137 (10 nM-10 µM), L-cysteine (100 nM-10 µM) and N-acetylcysteine (10 µM-1 mM) elicited a concentration-dependent decrease in K+-evoked [3H]D-aspartate release from isolated bovine retinae without affecting basal tritium efflux. At equimolar concentration of 10 µM, the rank order of activity was as follows: L-cysteine > GYY 4137 > N-acetylcysteine. A dual inhibitor of the biosynthetic enzymes for H2S, cystathionine β-synthase (CBS) and cystathionine γ-lyase (CSE), amino-oxyacetic acid (AOA; 3 mM) reversed the inhibitory responses caused by GYY 4137, L-cysteine and N-acetylcysteine on K+-evoked [3H]D-aspartate release. Glibenclamide (300 µM), an inhibitor of KATP channels blocked the inhibitory action of GYY 4137 and L-cysteine but not that elicited by N-acetylcysteine on K+-induced [3H]D-aspartate release. The inhibitory effect of GYY 4137 and L-cysteine on K+-evoked [3H]D-aspartate release was reversed by the non-specific inhibitor of nitric oxide synthase (NOS), L-NAME (300 µM). Furthermore, a specific inhibitor of inducible NOS (iNOS), aminoguanidine (10 µM) blocked the inhibitory action of L-cysteine on K+-evoked [3H]D-aspartate release. We conclude that both donors and substrates for H2S production can inhibit amino acid neurotransmission in bovine isolated retinae, an effect that is dependent, at least in part, upon the intramural biosynthesis of this gas, and on the activity of KATP channels and NO synthase.

Entities:  

Keywords:  Aspartate; Cystathionine β-synthase; Cystathionine γ-lyase; Hydrogen sulfide; KATP channels; Retinae

Mesh:

Substances:

Year:  2018        PMID: 29353375     DOI: 10.1007/s11064-018-2471-5

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  56 in total

1.  Inhibitory action of novel hydrogen sulfide donors on bovine isolated posterior ciliary arteries.

Authors:  Madhura Kulkarni-Chitnis; Ya Fatou Njie-Mbye; Leah Mitchell; Jenaye Robinson; Matthew Whiteman; Mark E Wood; Catherine A Opere; Sunny E Ohia
Journal:  Exp Eye Res       Date:  2015-04-04       Impact factor: 3.467

2.  Exogenous nitric oxide enhances the prophylactic effect of aminoguanidine, a preferred iNOS inhibitor, on bleomycin-induced fibrosis in the lung: Implications for the direct roles of the NO molecule in vivo.

Authors:  Chao Chen; Xiao-Jing Yun; Li-Ze Liu; Hong Guo; Lian-Feng Liu; Xiao-Ling Chen
Journal:  Nitric Oxide       Date:  2017-07-27       Impact factor: 4.427

3.  Hydrogen sulfide functions as a neuromodulator to regulate striatal neurotransmission in a mouse model of Parkinson's disease.

Authors:  Min Wang; Jun Zhu; Yang Pan; Jingde Dong; Lili Zhang; Xiangrong Zhang; Li Zhang
Journal:  J Neurosci Res       Date:  2014-11-11       Impact factor: 4.164

Review 4.  Hydrogen sulfide is a signaling molecule and a cytoprotectant.

Authors:  Hideo Kimura; Norihiro Shibuya; Yuka Kimura
Journal:  Antioxid Redox Signal       Date:  2012-03-02       Impact factor: 8.401

5.  Hydrogen sulfide-induced relaxation of resistance mesenteric artery beds of rats.

Authors:  Youqin Cheng; Joseph Fomusi Ndisang; Guanghua Tang; Kun Cao; Rui Wang
Journal:  Am J Physiol Heart Circ Physiol       Date:  2004-06-10       Impact factor: 4.733

6.  Regulation of [3H] D-aspartate release from mammalian isolated retinae by hydrogen sulfide.

Authors:  Catherine A Opere; Emmanuel M Monjok; Kaustubh H Kulkarni; Ya Fatou Njie; Sunny E Ohia
Journal:  Neurochem Res       Date:  2009-05-07       Impact factor: 3.996

7.  Hydrogen sulfide induces calcium waves in astrocytes.

Authors:  Yasuo Nagai; Mamiko Tsugane; Jun-Ichiro Oka; Hideo Kimura
Journal:  FASEB J       Date:  2004-01-20       Impact factor: 5.191

8.  The possible role of hydrogen sulfide as an endogenous neuromodulator.

Authors:  K Abe; H Kimura
Journal:  J Neurosci       Date:  1996-02-01       Impact factor: 6.167

9.  Pharmacological actions of the slow release hydrogen sulfide donor GYY4137 on phenylephrine-induced tone in isolated bovine ciliary artery.

Authors:  Madhura Kulkarni Chitnis; Ya Fatou Njie-Mbye; Catherine A Opere; Mark E Wood; Matthew Whiteman; Sunny E Ohia
Journal:  Exp Eye Res       Date:  2013-10-18       Impact factor: 3.467

10.  Hydrogen sulfide regulates Ca(2+) homeostasis mediated by concomitantly produced nitric oxide via a novel synergistic pathway in exocrine pancreas.

Authors:  Amira Moustafa; Yoshiaki Habara
Journal:  Antioxid Redox Signal       Date:  2013-10-19       Impact factor: 8.401

View more
  4 in total

1.  The effects of intravitreal H2 S application on apoptosis in the retina and cornea in experimental glaucoma model.

Authors:  Zuleyha Erisgin; Murat Atabey Ozer; Murat Tosun; Serkan Ozen; Selcuk Takir
Journal:  Int J Exp Pathol       Date:  2019-11-27       Impact factor: 1.925

Review 2.  Hydrogen Sulfide Biology and Its Role in Cancer.

Authors:  Saadullah Khattak; Mohd Ahmar Rauf; Nazeer Hussain Khan; Qian-Qian Zhang; Hao-Jie Chen; Pir Muhammad; Mohammad Azam Ansari; Mohammad N Alomary; Muhammad Jahangir; Chun-Yang Zhang; Xin-Ying Ji; Dong-Dong Wu
Journal:  Molecules       Date:  2022-05-25       Impact factor: 4.927

Review 3.  Hydrogen sulfide: a gaseous signaling molecule modulates tissue homeostasis: implications in ophthalmic diseases.

Authors:  Yuyi Han; Qianwen Shang; Jin Yao; Yong Ji
Journal:  Cell Death Dis       Date:  2019-03-29       Impact factor: 8.469

Review 4.  Hydrogen Sulfide (H2S)-Releasing Compounds: Therapeutic Potential in Cardiovascular Diseases.

Authors:  Lei Zhang; Yanan Wang; Yi Li; Lingli Li; Suowen Xu; Xiaojun Feng; Sheng Liu
Journal:  Front Pharmacol       Date:  2018-09-21       Impact factor: 5.810

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.